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a  b  s  t  r  a  c  t
In the  United  States,  chemical  additives  cannot  be used  in food  without  an  afﬁrmative  determination
that  their  use  is safe  by FDA  or additive  manufacturer.  Feeding  toxicology  studies  designed  to  estimate
the  amount  of  a  chemical  additive  that  can  be eaten  safely  provide  the  most  relevant  information.  We
analyze  how  many  chemical  additives  allowed  in human  food  have feeding  toxicology  studies  in threeeywords:
ood chemicals, Food additives, FDA, GRAS,
afe, Toxicology, Food contact substances,
lavors
toxicological  information  sources  including  the  U.S.  Food  and  Drug  Administration’s  (FDA)  database.  Less
than  38%  of  FDA-regulated  additives  have  a published  feeding  study.  For  chemicals  directly  added  to  food,
21.6%  have  feeding  studies  necessary  to estimate  a safe  level  of  exposure  and 6.7%  have  reproductive  or
developmental  toxicity  data  in FDA’s  database.  A  program  is needed  to ﬁll  these  signiﬁcant  knowledge
gaps  by  using  in  vitro  and  in  silico  methods  complemented  with  targeted  in  vivo studies  to ensure  public
health  is protected.
© 201. Introduction
More than 10,000 chemicals are allowed to be added, directly
r indirectly, to human food pursuant to the United States’ (US)
ood Additives Amendment of 1958 as administered by the U.S.
ood and Drug Administration (FDA) [1]. They perform many
oles, including preserving ﬂavor, enhancing taste or appearance,
reventing spoilage, and as constituents of packaging. As of 2010,
ver 90% of these additives were allowed in human food under
he legal categories known as “food additives” or as “generally
ecognized as safe” (GRAS) substances in roughly equal numbers.
RAS substances range from common food ingredients (such
s wheat) to newly engineered substances using biotechnology
1]. The remaining 10% are in smaller categories such as color
Abbreviations: FDA, U.S. Food and Drug Administration; EPA, U.S. Environmen-
al  Protection Agency; TOR, Threshold of Regulation; FCS, Food Contact Substances;
RAS,  Generally Recognized as Safe; FEMA, Flavor and Extract Manufacturers Asso-
iation; EAFUS, Everything Added to Food in the United States; CASRN, Chemical
bstract  Service Registry Number; PAFA, Priority-based Assessment of Food Addi-
ives.
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890-6238     ©   2013 The Authors. Published by Elsevier Inc. 
ttp://dx.doi.org/10.1016/j.reprotox.2013.07.023
Open access under CC BY-NC-SA li 3  The  Authors . Published  by  Elsevier  Inc. 
additives, pesticides, or substances whose use the federal
government sanctioned before the law was enacted in 1958.
By  law, food additives and GRAS substances (collectively
referred to in this article as chemical additives) cannot be used in
food without an afﬁrmative determination that their use is safe (21
U.S.C. §321 and §348) by FDA or, in some cases, the additive man-
ufacturer. Safety means that there is a “reasonable certainty in the
minds of competent scientists that the substance is not harmful
under the intended conditions of use” (21 CFR §170.30(i)). Also,
“no additive shall be deemed to be safe if it is found to induce
cancer when ingested by man  or animal” (21 U.S.C. §348(c)(3)(A))
[1]. Congress required afﬁrmative determinations and set strin-
gent standards for safety, acknowledging that the health effects of
chemical additives are often hidden or take years to show up. These
standards aim to protect the public as well as to encourage inno-
vation and build public conﬁdence in the safety of the food supply
[2].
In addition, a safety decision for a GRAS substance based on
scientiﬁc procedures must be supported by published studies
(whether peer-reviewed or not) (21 CFR §170.30(b)) and there can
be no genuine dispute regarding the chemical’s safety [3]. If an addi-
tive was in common use before 1958, safety may  be based on that
experience rather than scientiﬁc procedures (21 USC §321(s)).
In  1969, President Richard Nixon directed FDA to use updated
Open access under CC BY-NC-SA license.scientiﬁc procedures it had developed to reassess the safety of
food additives and GRAS substances that the agency had previously
approved [3,4]. In 1977, in the midst of this review, FDA told the
U.S. Senate that it “intended to extend the concepts of retrospective
cense.
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afety assessment of GRAS substances to potentially all chemicals
hat are added (directly or indirectly) to food in the United States”
5]. The agency cited changes in population exposure and advances
n toxicological testing since the early 1960s when many of the
dditives were ﬁrst approved.
As a result of this effort, in the late 1970s and early 1980s,
DA was at the leading edge of toxicological testing for chemi-
al additives. The main outcomes were the publication in 1982
f its landmark “Toxicological Principles for the Safety Assess-
ent of Direct Food Additives and Color Additives Used in Food”,
lso known as the “Redbook” [6], and the development of the
riority-based Assessment of Food Additives (PAFA) system [5] that
ncluded a database with toxicological information on direct addi-
ives (those added directly to food).
As part of this process, FDA established three “Concern Levels”
1, 2, and 3 with 3 being the most signiﬁcant concern) for direct
dditives and color additives and developed recommended min-
mum toxicity tests for each level. The Concern Levels are based
n a combination of estimated exposure and a prediction of the
oxicity based on structural similarity to chemical with known
azards. The agency uses the levels to determine “the extent and
ype of basic toxicological testing of an additive” [6,7]. For instance,
enetic toxicity tests and short-term toxicity tests with rodents
re recommended for Concern Level 1 chemicals. FDA recommends
dditional studies including reproduction and developmental tox-
city for Concern Levels 2 and 3, and human studies for Level 3.
hese recommendations remain in FDA’s guidance today [7].
The  Redbook [6] recommended how the toxicology studies tests
hould be conducted. These tools were designed to help the agency
nd stakeholders establish clear expectations for what toxicology
ata the agency would need to make safety decisions.
Pursuant to its commitment to the U.S. Senate, FDA also under-
ook a sustained effort to develop a strategy to reassess food
dditives and GRAS substances and documented its analysis in a
eries of peer-reviewed journal articles from 1981 to 1986 [8–10].
t did not evaluate indirect additives (chemicals used in packag-
ng or as food contact substances (FCS)) “partly because they pose
pecial problems of identiﬁcation and exposure assessment” [8].
In the process of developing PAFA and the strategy, FDA sci-
ntists evaluated the available toxicological information for 1586
irect additives [8]. Their search included information FDA already
ossessed (whether published or unpublished) and data from the
ational Institute of Occupational Safety and Health’s (NIOSH)
egistry of Toxic Effects in Chemical Substances (RTECS) database.
gency scientists only considered studies with ‘toxicological feed-
ng information’ (i.e. studies where an animal or a human ingested
 chemical regardless of duration or purpose), ﬁnding this informa-
ion on 658 of the chemical additives [8]. In addition, FDA scientists
oncluded that only 159 (10% of the total) underwent more than a
ingle dose toxicity test and had sufﬁcient information to estimate
he lowest effect level in any species tested [9]. Since the 1980s,
DA has continued to maintain the PAFA database but only include
hose additives it speciﬁcally approves through the formal rule-
aking process. Most FDA chemical safety reviews since 2000 do
ot go through this process.
Given FDA’s ﬁnding and the ongoing expansion of the addi-
ives market, the present study was undertaken to analyze how
any chemical additives currently allowed in human food have
ublished feeding studies.
.  Materials and methodsThe  authors conducted this research using a combination of
icrosoft Access 2010 and Excel 2010 to compile information. To
dentify chemical additives, we used Chemical Abstract ServiceFig. 1. Resources used to identify allowed chemical additives. Shaded boxes indicate
sources of chemical additive information used in the analysis.
*Includes  some chemical additives on FEMA GRAS ﬂavors list.
Registry Numbers (CASRN); these are assigned to unique chemi-
cals by the American Chemical Society. If the resource we used to
develop the list provided another identiﬁcation number instead of
a CASRN, we  used that number. Below is a brief description of the
methods.
2.1. Step 1: Develop master additives list
We imported the following lists or databases (see Fig. 1) of
chemicals allowed to be added to food and merged them into a
table.
• FDA’s  Priority-based Assessment of Food Additives (PAFA)
database provided by FDA on Oct. 15, 2012 containing chemical
information on:
◦ Direct additives in its “Everything Added to Food in the United
States”  (referred to as EAFUS additives) database; and
◦ Indirect additives in its “List of Indirect Additives Used in Food
Contact  Substances” (Indirects) database.
We  removed chemicals that FDA had prohibited from use in
food. There were 26 in “Everything Added to Food in the United
States” (EAFUS) list [11] and 5 in the “List of Indirect Additives Used
in Food Contact Substances” [12] (Arvidson, Personal Communica-
tion)].
• Notiﬁcations received and posted on the FDA’s website as of Feb.
7,  2012. For each program, we  reviewed the information avail-
able  on FDA’s website and captured the chemicals covered by
the  notice and, where available, CASRNs for those chemicals. We
reviewed:
◦ GRAS Notiﬁcations (GRN) [13]: Notices from food manufacturers
and  FDA response letters posted at FDA’s online database for 410
GRNs received from 1997-2011.
◦ FDA’s Food Contact Substance Notiﬁcations (FCN) [14]: Summa-
ries  posted on online database for the 773 notices received since
2000  to which the agency had no objection.
◦  FDA’s Threshold of Regulation Submissions (TOR) [15]: Summ-
aries  posted online for 105 exemption requests granted by FDA
since  1996.
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Environmental  Protection Agency’s (EPA) pesticides with toler-
ances  or exemptions in 581 sections at 40 CFR Part 180 [16] as of
Jan. 1, 2012.
Flavor and Extract Manufacturers Association’s (FEMA) [17] list
of GRAS substances provided by the organization as reported in
its 25 GRAS publications since 1963 (Gavin, Personal Communi-
cation)  on Dec. 15, 2011.
We generated the master additives list by reﬁning the table as
ollows:
(a) Used National Institute of Standards and Technology (NIST)
search  engine [18] to identify CASRNs for simple chemical
names for chemical additives without CASRNs or other iden-
tiﬁcation  number (provided by FDA or FEMA);
b) Removed chemicals additives that still lacked CASRNs or other
identiﬁcation number but kept those that FDA and FEMA
assigned because they were in FDA’s database and they were
used  in other documents;
(c) Combined information from the same number; and
d) Removed chemicals used only as pesticides and kept those also
approved  to be used as food additives.
.2.  Step 2: Identify sources of toxicological information
We used three sources of toxicology information:
. FDA’s PAFA database containing toxicology information for
EAFUS  additives as of Oct. 15, 2012. It contains published and
unpublished studies and includes results from:
 Acute lethal dose 50 (LD50) studies: study designed to calcu-
late  the amount of chemical needed to kill 50% of the study
population, Oral studies: study designed to estimate the no-
observed-adverse-effect-level (NOAEL), relevant to estimate the
safe level of exposure; and
 In vitro tests for genetic toxicity: designed to test for mutageni-
city.
 Minimum toxicity testing levels assigned by FDA based on levels
of  concern.
We also conﬁrmed that there is a one-to-one correspondence
etween “Doc#” (FDA’s key for each chemical) and CASRN; matched
ASRNs among the six “functions” identiﬁed by FDA (GRAS, ﬂavor,
ndirect, direct, color or prior-sanctioned); and combined informa-
ion of records with the same CASRN.
In addition to the ﬁles containing toxicology information, we
dentiﬁed:
 FDA’s grades the completeness of many of the oral studies. The
lowest  grade is a “C” which indicates it does not meet the agency’s
core  standards.
“A”  grade means it meets its “Toxicological Principles for the
Safety  Assessment of Food Additives”, also known as the Redbook,
standards.
“B”  grade when they met  some, but not all of FDA’s basic stan-
dards.
“C”  grade means it does not meet basic standards.
 Seven formats referring to sources that appear to be inconsistent
with  those used to identify articles in published journals. These
formats  start with the letters: ASP, CAP, FAP, FEM, FMF, GRM, or
GRP. We  considered these to be unpublished studies. They were
most  likely submitted to FDA as part of a notice or petition.Toxicology 42 (2013) 85– 94 87
2.  Accelrys’ “Toxicity” database (Accelrys) as of Feb. 29, 2012. This
database  contains published toxicology information from more
than  114,000 studies in 3770 publications on more than 174,000
chemicals  from three sources (Host, Personal Communication):
◦ Registry of Toxic Effects of Chemical Substances (RTECS) built
and  maintained by National Institute of Occupational Safety and
Health (NIOSH) from 1971 to 2000. Since 2001, the private ﬁrm,
Accelrys,  has updated the information using the same data selec-
tion  criteria and rules used by NIOSH [19].
◦  U.S. National Cancer Institute’s Chemical Carcinogenesis
Research Information System (CCRIS) with over 9000 chemical
records  with carcinogenicity, mutagenicity, tumor promotion,
and  tumor inhibition test results [20].
◦  GENE-TOX by EPA with test data, resulting from expert peer
review  of the open scientiﬁc literature on over 3000 chemicals
[20].
3. U.S. National Library of Medicine’s (NLM) TOXLINE database
of  more than 4 million published bibliographic references that
include  PubMed and MEDLINE as of March 13, 2012 [21].
2.3. Step 3: Compare master additives list to PAFA and Accelrys
toxicology information
We  deﬁned feeding studies to mean both oral (as deﬁned by
FDA and described in Section 2.2 Step 2) and LD50 where the expo-
sure was  via ingestion (including gavage). Although there is a broad
spectrum of feeding studies with different duration and endpoints,
we focused on the route of administration only because these were
the two  categories used by FDA in its database.
As mentioned above, PAFA only has toxicology data for EAFUS
additives. We  did the following comparisons to the Master Addi-
tives List:
• Matched  chemical additives with Accelrys’ toxicology data. We
provided Accelrys with the names and associated CASRNs or iden-
tiﬁcation numbers to match against its “Toxicity” database. The
ﬁrm  provided us with a list of chemicals for which there is a record
of  toxic effect by feeding only or any route of exposure.
• Matched EAFUS chemical additives with PAFA toxicology data,
identifying  chemicals that had data in either oral or LD50 studies.
• Identiﬁed  those direct additives in EAFUS that FDA has assigned
a  Concern Level 2 or 3 in PAFA and matched them with PAFA
reproductive and developmental toxicology data, identifying
chemicals that had data in either study. In its guidelines, the
agency  recommends that chemicals that fall under any of these
levels  are tested for reproductive and developmental toxicity [7].
None of this information was  available in the other databases.
2.4. Step 4: Compare Accelrys results to TOXLINE and PAFA
toxicology information
We  recognize the possibility that Accelrys may  have missed
published feeding studies. Therefore, we  used the U.S. National
Library of Medicine’s TOXLINE search engine [21] to identify
whether feeding toxicology studies could be identiﬁed where
Accelrys did not. We  used the following process to conduct the
review:1. Divided our Master Additives List into two parts: EAFUS additives
(to  compare to PAFA) and non-EAFUS additives.
2.  Reﬁned each list to include only those chemicals that did not
have  information from a feeding study in Accelrys. We  limited
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Fig. 2. Number of EAFUS additives with feeding toxicology studies in PAFA.8 T.G. Neltner et al. / Reprod
the search to identify the rate of false negatives for feeding data
in  the Accelrys review.
. Selected a sample size sufﬁcient to be 95% conﬁdent that less
than  10% of the chemicals without feeding studies results in
Accelrys  had feeding studies in TOXLINE (a desired conﬁdence
interval of 10%) for each list. We  used the Macorr Research Solu-
tions  calculator [22].
. Developed a random selection of chemical additives using Excel.
. Entered the CASRN and selected “oral” as the route of exposure
for  each additive in TOXLINE Advanced search engine [21].
. Searched using the additive’s name where a CASRN search
returned an error in TOXLINE (where FDA, FEMA, or another
entity  assigned numbers to some additives). If name search
yielded  no results, then we looked for a true CASRN for the chem-
ical  using National Institute of Standards and Technology search
engine  and repeated the TOXLINE search using that CASRN.
. Recalculated conﬁdence interval based on the results from the
searches.
. Used the following equation to calculate the results:
Estimated number of additives lacking publicly-available feed-
ng studies in TOXLINE = number of additives without feeding study
esults in Accelrys × (1 − conﬁdence interval − percent of random
ample found to have feeding studies in TOXLINE).
.5. Estimating the frequency of references to FDA’s minimum
ecommended testing
We  reviewed the 410 GRAS notices available from FDA’s GRAS
otice Inventory as of Feb. 7, 2012. For each of them, we  searched
or the following key terms:
.  Reproductive toxicity
. Developmental toxicity
. Concern levels or Levels of Concern
.  Redbook or Toxicological Principles (a short version of the ofﬁcial
title  Toxicological Principles for the Safety Assessment of Food
Ingredients)
We  listed all GRAS notices with their corresponding link to FDA’s
nventory website and recorded the frequency of appearance of
ach of these terms in each notice. Then, we calculated the per-
entage of notices that made a reference to any of the following:
.  Performing Reproductive Toxicity testing;
.  Performing Developmental Toxicity testing;
.  Identifying the Concern Level of the chemical; and
. Following the Redbook toxicology studies recommendations.
. Results
.1. Analysis of lists of additives
FDA’s  PAFA database contained chemical information on 7169
hemical additives from its on-line EAFUS and Indirects databases
see Supplementary materials database). Most of the chemicals
ere identiﬁed by CASRNs. However, FDA assigned a number for
367 (19%) of these chemicals that follows the style of CASRNs [8].
The master additive list contained 8105 chemical additives
ith CASRNs or other identiﬁcation numbers drawn from seven
esources (see Supplementary materials database). Fig. 1 depicts
he analysis and provides the total number of chemicals for PAFA
nd the Master Additives List. The list does not include 501 additives
ithout codes provided by the resource or with readily identiﬁ-
ble CASRNs (80% from FDA notiﬁcation programs and the balanceAbbreviations:  EAFUS: Everything Added to Food in the United States; PAFA:
Priority-based Assessment of Food Additives; LD50: Lethal Dose to kill half of study
population.
from EPA pesticide rules) and 384 chemicals used exclusively as
pesticides.
The master additive list contained 936 chemical additives not on
EAFUS or Indirect lists in PAFA: 344 on FEMA only; 128 on GRN only;
399 on FCN only; 53 on TOR only; 4 on both FEMA and GRN; and 8
on both FCN and TOR. Each of the three FDA notiﬁcation programs
identiﬁed one pesticide not listed in PAFA.
3.2. Analysis of PAFA toxicology information for EAFUS additives
PAFA  contains toxicology information for the 3941 direct addi-
tives listed in the EAFUS (referred to as EAFUS Additives) (see
Supplementary materials database). These are chemicals allowed
to be added directly to food at some stage of food production or
processing as opposed to those only allowed to come in contact
with food (known as indirect additives or food contact substances
(FCS)).
The toxicology information is separated into two types of feed-
ing studies: oral and LD50. We  found 852 (21.6%) of EAFUS additives
had oral studies, 1110 (28.2%) had LD50 studies, and 1422 (36.1%)
have one or both. In other words, 63.9% had no feeding data (Fig. 2).
Table 1 summarizes the number of EAFUS additives with oral or
LD50 studies based on the additive’s function assigned by FDA in
PAFA.
For the 3941 EAFUS additives, only 263 (6.7%) had reproductive
toxicology and teratology data, and two had developmental toxi-
cology measurements. In PAFA, FDA assigned 1136 EAFUS additives
as Concern Levels 2 or 3. For these levels, FDA recommends repro-
duction studies and developmental toxicity studies among others
[7]. Of these 1136 additives, 137 (12%) had reproductive or devel-
opmental toxicity data.
For the 1422 chemicals with feeding data, we found 5093 stud-
ies:
• 1286  LD50 studies 39% of which were unpublished (submitted to
FDA without being made publicly available);
• 3807  oral studies 32% of which were unpublished;
• Of  the 3807 oral studies, FDA graded studies based on whether
they  conform to its toxicological guidance to industry:
◦ 7% conformed to guidance;
◦ 16% met  only core standards (standards used by agency before
the  1982 guidance [5]);
◦ 47% do not meet the core standards; and
◦  30% were ungraded.
Of the 852 EAFUS additives with an oral study, 293 (34%) had
only studies that FDA graded as not meeting its core standards or
guidance. FDA also included overall comments on the toxicological
data such as:
• “No  tox data” for 784 (19.9%) chemicals; and
• “Data Insufﬁcient” for 272 (6.9%) chemicals.
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Table  1
Number of Everything Added to Food in the United States (EAFUS) additives with feeding studies in priority-based Assessment of Food Additives (PAFA) percentage compares
number to total additives with same function.
Function* No. with an oral study No. with a LD50 study Total EAFUS additives
Direct 677 (20.9%) 959 (29.6%) 3238
Flavor  511 (17.3%) 866 (29.4%) 2950**
GRAS 566 (19.3%) 857 (29.2%) 2938
Color  65 (59.6%) 51 (46.8%) 109
Prior-sanctioned*** 12 (14.6%) 13 (15.9%) 82
At  least one of the ﬁve functions 852 (21.6%) 1110 (28.2%) 3941
GRAS = Generally recognized as safe.
LD50  = Lethal dose to kill half the study population.
* Chemicals typically have multiple functions.
** FDA designates more chemicals as ﬂavors than are on the Flavor and Extract Manufacturers Association’s GRAS Flavor list.
*** Prior-sanctioned refers to chemical additives approved by the federal government prior to 1958.
8105 additiv es on Master 
Additiv e List 
(3941  EA FUS additi ves and  
4164 no n-EAFUS  ad diti ves)
> 16 0,000  chemicals 
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EPA  
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published  feeding 
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Fig. 3. Number of chemicals in master additive list with feeding toxicology data in
Accelrys.
Abbreviations: NIOSH: National Institute for Occupational Safety and Health; RTECS:
Registry of Toxic Effects of Chemical Substances; NCI: National Cancer Institute;
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o Food in the United States; CASRN: Chemical Abstract Service Registry Number.
.3. Analysis of Accelrys toxicology information
We found that 28.6% of the 8105 chemical additives on the mas-
er additive list had feeding study data in the Accelrys “Toxicity”
atabase of published studies (Fig. 3). We  did not ask Accelrys to
istinguish between oral studies and LD50 studies. (see Supple-
entary materials database)
Table  2 provides the results for each of the resources used
o identify chemical additives. For EAFUS additives, 66.3% lacked
oxicology data, which is similar to the 63.9% lacking studies in
AFA. For non-EAFUS additives, 76.3% lacked feeding study data.
e included the number of additives with any study results, not
ust feeding studies, to provide context. Note that FDA does not
ecommend feeding studies for food contact substances when esti-
ated exposure is low [23]. It is important to note that Accelrys
id not ﬁnd any feeding studies for the 1380 chemical additives
ssigned a number by FDA or FEMA.
.4. Comparison of Accelrys to TOXLINE
Recognizing that Accelrys may  be missing studies, especially
here FDA or FEMA assigned an identiﬁcation number, we  checked
hether the same chemical additive without feeding data in Accel-
ys also lacked information in NLM’s TOXLINE. Our evaluation
rovided the following results:
EAFUS Additives: Accelrys did not identify feeding studies for
2612  additives or 66.3% of all EAFUS additives. We  randomly
selected 96 chemical additives from these and searched TOX-
LINE  for feeding studies. Of the 96, 31 additives had numbers
assigned by FDA. Therefore, we searched using variations of the
chemical  names. We  found feeding studies for 11 (11.5%) of the
96.  The recalculated 95% conﬁdence interval was 6.4%. Using thein PAFA and Accelrys databases.
Abbreviations:  EAFUS: Everything Added to Food in the United States; PAFA:
Priority-based Assessment of Food Additives.
equation described in Section 2 Step 4, we estimated that at least
54%  of EAFUS additives do not have published feeding studies in
TOXLINE.
• Non-EAFUS Additives: Accelrys did not have feeding studies for
3179 additives or 76.3% of all non-EAFUS additives. We  randomly
selected  117 additives from these and searched TOXLINE for feed-
ing  studies. Of the 117, 29 additives had numbers assigned by
FDA.  Therefore, we searched using variations of the chemical
names.  We  found feeding studies for only 9 (7.7%) of the 117. The
recalculated  95% conﬁdence interval was 4.8%. Using the equa-
tion  described in Materials and Methods Step 4, we estimated
that  at least 67% of non-EAFUS additives do not have published
feeding studies in TOXLINE.
Overall, we  can be 95% conﬁdent that at least 62% of the chem-
icals on the Master Additive List do not have published feeding
studies in TOXLINE.
3.5.  Combined Accelrys and PAFA toxicology information for
EAFUS  additives
We  found that 54% of EAFUS additives lack feeding studies in
both Accelrys and PAFA databases (Fig. 4).
PAFA and Accelrys both draw from all published studies. How-
ever, PAFA also includes unpublished studies. In addition, PAFA
uses identiﬁcation numbers instead of CASRNs for 17% of EAFUS
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Table 2
Number of chemical additives on Master Additive List with studies in Accelrys database (percentage compares number to total additives from same resource).
Resource used to identify additive* No. with any
study  results
No. with any
feeding  studies
Total additives
from resource
PAFA database
Everything Added to Food in United States (EAFUS) Additives 2568 (65.2%) 1329 (33.7%) 3941
Indirects  Additives 1414 (43.7%) 810 (25.1%) 3233
FDA  notiﬁcation programs
Generally  Recognized as Safe (GRAS) Substances 131 (68.6%) 73 (38.2%) 191
Food  Contact Substance (FCS) 352 (54.5%) 202 (31.3%) 646
Threshold  of Regulation (TOR) Substances 76 (76.8%) 46 (46.5%) 99
Flavor and Extract Manufacturers Association (FEMA) GRAS Flavors 2059 (75.3%) 1023 (37.4%) 2735
43
F
a
P
•
•
•
3
s
a
s
t
u
3
t
m
r
e
1
2
3
4
4
d
a
d
s
w
m
r
o
F
vAt  least one of the resources 
DA = U.S. Food and Drug Administration.
* Chemicals may appear on more than one resource.
dditives. Of the 503 EAFUS additives with feeding studies only in
AFA:
178  (35%) had only unpublished studies;
115  (23%) had identiﬁcation numbers assigned by FDA; and
282  (56%) had toxicology studies other than feeding in Accelrys.
.6. Consistency of results across all three toxicology information
ources
Our  analysis indicates that fewer than 38% of the chemical
dditives (direct and indirect) regulated by FDA have been the
ubject of a published feeding toxicology study. Table 3 provides
he results for each of the three sources of toxicology information
sed in our analysis.
.7.  Frequency of references to FDA’s minimum recommended
esting
The 327 GRAS notices provide a window into whether additive
anufacturers and FDA consistently follow the agency’s guidelines
egarding the minimum toxicity tests to be performed for safety
valuation of direct additives.
We  found that:
.  (1%) notices assigned the chemical additive a Concern Level (a
critical  step to determining necessary testing according to FDA
recommendations);
. 75 (23%) notices reported results for developmental toxicity
studies;
. 120 (37%) notices reported results for reproductive toxicity stud-
ies;  and
. (<1%) notices assigned a Concern Level and reported results for
both  reproductive and developmental toxicity studies.
. Discussion
Almost two-thirds of chemical additives appear to have been
eclared safe for use in food without the beneﬁt of being fed to an
nimal in a controlled toxicology study. For the chemicals added
irectly to food that are listed in EAFUS, the results are better but
till less than half have any feeding studies. Interestingly, there
as excellent correlation among the three distinct toxicology infor-
ation sources used in the analysis (Table 3). Where the agency
ecommended reproductive or developmental toxicity testing only
ne in eight had any data.
Virtually  all EAFUS additives were initially allowed in food by
DA or FEMA before 1997. Since then, additive manufacturers have
oluntarily notiﬁed FDA of their GRAS safety decisions of 191 new64 (53.8%) 2314 (28.6%) 8105
direct  chemical additives with CASRNs through the agency’s GRAS
notiﬁcation program. These do not appear in EAFUS [1]. We  found
that more than 60% of these chemicals were approved by the
additive manufacturer and reviewed by FDA without a published
feeding study (Table 2), despite a requirement at 21 CFR 170.30 that
the GRAS determination be based on a published study (regardless
of route of administration).
In  order to avoid overestimating the data gap, our estimates are
based on all feeding studies including LD50 studies, which have
limited relevance to chemical additive safety. Knowing how much
it takes to kill half a study population may  be useful to design addi-
tional studies but not to identify how much consumers can eat
without harm. Oral studies (those designed to estimate a NOAEL)
are the most relevant to determine a safe level of exposure. Yet,
we found that 78.4% of EAFUS additives lacked oral studies in FDA’s
toxicology database (Table 1).
These results are consistent with FDA’s own analysis of almost
1600 EAFUS additives published in 1985. The agency found that
90% had insufﬁcient toxicological data [9]. We believe that the dif-
ference between our ﬁndings and FDA is that the agency’s analysis
excluded studies it graded as inadequate. In contrast, we  included
all studies without assessing their adequacy, since such a review is
best done by the agency.
4.1.  What are the limitations to the analysis?
Although our ﬁndings strongly suggest a substantial data gap,
we acknowledge that our methodology has limitations, including:
• The  three toxicology resources may  not capture the entire uni-
verse  of studies, particularly unpublished ones. PAFA contains
about  5000 feeding studies. Accelrys has about 114,000 studies
of  all types (Host, Personal Communication) and TOXLINE pro-
vides  access to more than 4 million [20]. We were not able to
identify  other sources that were as comprehensive.
• Review  studies such as the Scientiﬁc Literature Reviews pub-
lished  by the National Technology Information Service were not
consistently  included by NIOSH in RTECS and, therefore, may  not
all  be in Accelrys. Since the ﬂavor industry relied heavily on these
reviews,  the percentage reported for these chemical additives is
likely understated.
• Accelrys and TOXLINE only contain published studies draw-
ing  heavily from scientiﬁc journals. We offset this limitation
with  unpublished studies in PAFA for EAFUS additives that FDA
received  through food additive petitions or other means. We  did
not  seek unpublished studies from FDA that were not described
in  PAFA or from other organizations.
• We  did not conduct a chemical-by-chemical search in TOXLINE.
Instead,  we calculated a representative sample size of chemical
additives  without a feeding study in Accelrys. If the CASRN and
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Table  3
Percentage of chemical additives with feeding toxicology studies.
Source of toxicology information EAFUS additives* Non-EAFUS additives** Chemical additives on master additive list
FDA’s Priority Assessment for Food Additives (PAFA) database 36.1% (Figure 2) Not applicable Not applicable
Accelrys’  “Toxicity” database*** 33.7% (Table 2) 23.7% (Table 2) 28.6% (Figure 3)
Accelrys  and PAFA combined 46% (Figure 4) Not applicable Not applicable
National  Library of Medicine’s TOXLINE database <46% <33% <38%
FDA = U.S. Food and Drug Administration.
EAFUS  = Everything Added to Food in the United States.
* 3941 chemicals in EAFUS allowed to be added directly to food.
** 4169 chemicals with Chemical Abstract Service Registry Numbers (CASRNs) not in FDA’s EAFUS database that are:
1) On its indirect additives database;
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*** Includes Registry of Toxic Effects of Chemical Substances (RTECS).
oral route of exposure were not properly designated, we would
not  have found feeding studies in TOXLINE.
We  did not ﬁnd studies in Accelrys for chemical additives in PAFA
that  had identiﬁcation numbers assigned by FDA or FEMA. We  off-
set this limitation by supplementing Accelrys with toxicological
information in PAFA as well as conduct searches in TOXLINE to
estimate  the 95% conﬁdence level.
Our  analysis excluded almost 400 chemical additives identiﬁed
through  FDA’s notiﬁcation programs that lacked CASRNs. These
are  not in PAFA. Our experience with Accelrys indicated that ﬁnd-
ing results based on chemical names searches is difﬁcult. We
opted  not to include these chemicals because they would have
made  the data gap appear larger than it might actually be.
FDA  did not assign Concern Levels to all the chemicals in EAFUS.
We  focused only on those that were clearly identiﬁed as level 2
or  3 because the agency recommended that additives with these
levels  be tested for reproductive and developmental toxicity.
Because FDA does not have a system to track usage of chemi-
als, it is unknown whether all of the allowed chemical additives
re currently being used to process foods. In addition, there are an
stimated 1000 chemical additives for which FDA has no informa-
ion as to their names, uses, and in which foods they currently are
sed [1].
However, even considering these limitations, the major data
aps raise signiﬁcant questions.
.2. How did we end up with so many chemical additives allowed
n food without feeding studies?
We identiﬁed ﬁve reasons for the data gaps.
Congress  allowed FDA and food manufacturers to make GRAS
determinations based on experience with the chemical’s com-
mon  use in food prior to 1958 rather than with scientiﬁc
procedures.
FDA approved thousands of chemical additives before it deﬁned
safety  or issued guidance establishing how a safety determination
should be done. In one case in which FDA approved hundreds of
chemicals, the agency used ‘unwritten assumptions’ and made
safety  decisions on ‘wish lists’ submitted by industry, according
to  industry lawyers [24].
FDA  [23] and FEMA [25] rely on thresholds of exposure for food
contact  substances and ﬂavors below which no feeding studies
were  expected.
Once  FDA or an additive manufacturer determines a chemical is
safe to add to food, industry has little incentive to conduct addi-
tional  studies. In addition, FDA does not systematically review its
previous decisions. So if studies were not available for the initial
approval,  it is unlikely they would be conducted later.facturers Association (FEMA).
• Academic  researchers are unlikely to conduct studies to ﬁll the
gaps  without a red ﬂag that suggests a chemical poses a problem,
and  without funding available for such work.
4.3.  How did we end up with so many chemical additives allowed
in food without reproductive and developmental toxicity studies?
We  identiﬁed a few reasons:
• These studies are not explicitly required
• These  studies are costly and time consuming.
• Our  analysis of the GRAS notices submitted to FDA in the last
15  years strongly suggest that neither the manufacturer not the
agency’s  reviewers consistently follow the minimum recommen-
dations  established by FDA for direct additives. These ﬁndings
indicate  that the voluntary notiﬁcation programs may not have
contributed  to ﬁlling the reproductive and developmental tox-
icology  data gaps. This is disconcerting considering that, for
chemical  additives in PAFA, the agency had knowledge of the lack
of studies through the notiﬁcations.
4.4. Does the lack of toxicology studies for so many chemical
additives represent a public health problem?
The law prohibits food manufacturers from using a chemical in
food until its use is afﬁrmatively determined to be safe (21 U.S.C.
§321 and §348) by FDA or, in some cases, the additive manufac-
turer. This means “there is a reasonable certainty in the minds
of competent scientists that the substance is not harmful under
the intended conditions of use” (21 CFR §170.3(i)). If a chemical is
added to food without this afﬁrmative determination, the food is
adulterated (21 USC §342(a)(2)(C)).
When  estimated consumer exposure to FCSs is below exposure
thresholds set by FDA, the agency has determined that feeding
studies are not needed because these amounts are toxicologically
insigniﬁcant [23]. This premise has been disputed, especially when
FDA established the thresholds based on incomplete toxicology
data and out-of-date scientiﬁc methods [26,27].
Professional judgment by competent scientists is central to
safety determination and is needed to review the literature, esti-
mate cumulative exposure, select the appropriate safety factor, and
evaluate the available toxicological information. When applied in
a consistent and transparent manner, it can help to ﬁll in the gaps
where a chemical is missing toxicology information. Usually, this is
done by looking at the safety of similar chemicals, especially those
with a long history of use, and inferring that the health impacts
would be the same; however, given the substantial lack of tox-
icology data for chemical additives, extrapolation of the limited
information to so many chemicals is disconcerting and may  be
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nsufﬁcient to ensure safety. Therefore, it may  represent a public
ealth problem.
.5.  Why  has FDA not addressed the problem?
FDA certainly is aware there are signiﬁcant data gaps. Thirty
ears ago, FDA scientists knew that 90% of 1600 direct additives in
AFUS lacked sufﬁcient data [10]. To date, the agency acknowledges
ts lack of toxicological information for as many as 1000 EAFUS
dditives [11].
We  posit that FDA has not ﬁlled the gaps for three reasons.
.  It has determined that professional judgment is sufﬁcient espe-
cially  when exposures are estimated to be low (21 CFR §170.39)
[23].
.  It is has limited authority to require companies to tell the agency
how  much of a chemical additive is used or to demand additional
testing.
. If it wanted to conduct the research itself, its resources are
limited.
In  the 1980s, FDA did have a plan to reassess chemical addi-
ives with data gaps. The 1982 Redbook [6] contained the agency’s
ramework for reassessment recognizing that additional toxicity
nformation may  be needed because either the original data were
nsufﬁcient to make a ﬁnal determination or “[a]dditives once
pproved do not always remain static relative to the exposure and
oxicological criteria used originally to evaluate their safety” [5].
Five years later, an FDA scientist who later directed the food
dditive program recommended three criteria to determine when
 safety decision needs to be reviewed [28].
Toxicological  information is either inadequate or nonexistent or
clearly indicates the potential of the compound to produce toxic
response  of higher concern at doses that are low enough to bring
the  present margin of safety into question. In our analysis, we
were  unable to identify any program designed to ﬁll the data gaps.
In addition, our evaluation of the three notiﬁcation programs that
FDA launched in the 1990s suggests that shrinking the data gap
has  not been a priority (see Table 2). It is important to note that
vast  majority of FDA’s reviews since 2000 are conducted through
these  three programs [1].
Chemical  structure indicates higher than usual presumptive
concern. Through its Chemical Evaluation and Risk Estimation
System  (CERES), FDA has made a signiﬁcant effort to develop
computational and predictive methods to identify chemicals of
concern [29]. It is scheduled to be released in 2014 and, unless it
undergoes third-party validation, its use as the basis of regulatory
decision-making is limited.
More  than 100,000 pounds of the chemical is used in food
annually.  At the time of the analysis, FDA relied on information
voluntarily submitted by industry to the National Academy of
Sciences (NAS). This program ended in 1987 [30].
FDA lacks the authority to track annual usage of additives
unlike EPA, which has such authority for industrial chemicals
nd pesticides), leaving the agency unable to apply this criterion.
or example, pesticide manufacturers and processors must report
nnually to EPA on their production. In addition, pursuant to the
oxic Substances Control Act (TSCA), EPA requires manufacturers
nd processors of most organic chemicals to report detailed infor-
ation (including the amount processed) every ﬁve years underts Chemical Data Reporting rule [31]. Unfortunately, by statute
he information collected by EPA on chemical substances expressly
xcludes the amount used in food (15 U.S.C. §2602(2)(B)(vi)). If
hemical additives to food were not excluded, EPA would have beenToxicology 42 (2013) 85– 94
able to provide FDA with production data on more than 3776 (47%)
additives subject to EPA’s Chemical Data Report rule.
We  believe the criteria are still relevant a quarter century after
they were proposed.
4.6.  What should FDA do to ﬁll the data gaps?
While feeding toxicology studies serve a critical function in
safety determinations, it would be impractical to ﬁll the data gaps
solely through a massive new in vivo testing program applicable to
all additives, especially in light of animal welfare concerns. Unlike
in the 1980s when FDA established PAFA, today two powerful tools
are being developed that, together, can be used to set priorities:
computational toxicology and high-throughput in vitro testing.
Computational toxicology involves the use of sophisticated
computer-based chemical structure modeling supported by exist-
ing toxicology data to identify chemicals with potential hazards.
FDA used these methods to develop its Endocrine Disruptor Knowl-
edge Base [32] that identiﬁes potential endocrine disruptors,
including more than 200 additives. The agency is also developing
CERES (as discussed above). EPA and the National Institutes of Envi-
ronmental Health Sciences (NIEHS) have similar efforts underway
[33].
To increase the “ability to evaluate the large numbers of
chemicals that currently lack adequate toxicological evaluation”
[34], FDA has partnered with the National Toxicology Program
(NIEHS/NTP), the NIH Chemical Genomics Center (NHGRI/NCGC),
and the EPA’s Ofﬁce of Research and Development (EPA/ORD)
to develop and implement ‘Tox21′ [33,35]. This program uses
high-throughput in vitro testing and robotic equipment to run
large numbers of chemicals across a wide range of concentra-
tions and cell types to rapidly screen them for potential toxicity.
While still early, preliminary analysis indicates this approach is
useful to set priorities for additional evaluation. The success of
this program “is expected to result in test methods for toxic-
ity testing that are more scientiﬁcally and economically efﬁcient
and models for risk assessment that are more biologically based”
[34] while reducing or replacing the use of animals in regulatory
testing.
We identiﬁed two useful examples FDA could consider to
address the information gaps:
• European Food Safety Authority (EFSA) reviews: The European
Commission established EFSA in 2002 to serve as an independent
source  of scientiﬁc advice and communication on risks associated
with  the food chain. It directed EFSA to reevaluate by 2020 the
safety  of all chemical additives permitted for use in the Euro-
pean  Union before 2009 [36]. To accomplish this, EFSA convenes
expert  panels and asks industry to provide missing information,
but  it cannot order testing. EFSA’s published framework states
that  additives will continue to be used until their review is com-
plete.
• EPA’s  High Production Volume (HPV) Challenge program [37]: In
response to a report by the Environmental Defense Fund (EDF)
[38],  in 1998, EPA conﬁrmed that there were signiﬁcant gaps in
the available toxicology information for HPV chemicals (those
produced  over 1 million pounds annually). Later that year, EPA,
EDF  and the American Chemistry Council “challenged” industry
to  voluntarily ﬁll the information gaps. As a result, while cer-
tainly  many data gaps remain [39], by 2004 companies sponsored
more  than 2200 chemicals and submitted about 6500 published
and  more than 8100 unpublished studies [40]. They also began
testing  to ﬁll many of the remaining gaps [37]. EPA commit-
ted  to using its authorities under TSCA to require testing for
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unsponsored chemicals and to making the data available through
its  HPV Information System.
Both of these examples, however, would be difﬁcult for FDA to
dopt. Unlike EFSA, it lacks the authority and resources to establish
 comprehensive reassessment program. Unlike EPA, it lacks the
uthority to systematically require testing.
. Conclusions
A  chemical additive is safe only if there is reasonable certainty
n the minds of competent scientists that the substance is not
armful under the intended conditions of use. With almost two-
hirds of chemical additives lacking feeding toxicology and 78.4%
f additives directly added to food lacking data to estimate a safe
evel of exposure and 93% lacking reproductive or development
oxicity testing, it is problematic to assert that we know with rea-
onable certainty that all chemical additives are safe. Although FDA
s aware of the problem, it lacks the authority and resources to ﬁll
he information gaps. Furthermore, once a chemical is approved,
anufacturers have no incentive to add additional toxicology infor-
ation because FDA neither has a reassessment program in place
or has authority to require additional testing.
Many of the decisions were made decades ago often based on
xtrapolations from limited data. Therefore, a program is needed
o effectively and efﬁciently ﬁll the signiﬁcant information gaps to
nsure public health is protected. This program should set priorities
sing various tools including in vitro and in silico (such as compu-
ational toxicology) methods complemented with the selective use
f in vivo studies. In addition, the agency needs to seek authority to
ollect the information it needs and require testing when needed.
FSA’s reassessment program and EPA’s HPV Challenge program
re two examples to be considered.
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